R. Du

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

Deborah S. Barkauskas, B. Halmos, C. Flask, 2008, British Journal of Cancer.

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells

N. Azizian, Yulin Li, R. Du, 2020, BMC cancer.

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

J. Ji, Xiaoxiao Hu, S. Cheung, 2015, Molecular Cancer Therapeutics.

New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical properties.

A. Bohm, Revital Yefidoff-Freedman, Qingwen Zhang, 2019, European journal of medicinal chemistry.

The CD200–CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K

D. Owens, Jiyoon Cho, R. Du, 2021, Cancer Research.

RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors

N. Rosen, Paul D. Smith, Xiaoxiao Hu, 2020, Molecular oncology.

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells

N. Azizian, Yulin Li, R. Du, 2021, BMC Cancer.